Qumis | $2,200,000 | (Jan 22, 2025)
Highnote | $90,000,000 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Certified by Founder
Lodge
Laplace Interventional
start up
United States
- Plymouth, MN
- 25/07/2023
- Series B
- $12,900,000
Laplace Interventional is developing a minimally invasive transcatheter treatment for patients suffering from Tricuspid Regurgitation.
- Industry Medical Equipment Manufacturing
- Website N/A
- LinkedIn https://www.linkedin.com/company/laplaceint/
Gravity(US) | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
Percipio Health | $20,000,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)